Your Messages Inbox
Your Article Summary
See Latest ArticlesSalix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Salix Pharmaceuticals, Ltd. announced the U.S. Food and Drug Administration has granted marketing approval for METOZOLV™ ODT 5mg and 10mg orally disintegrating tablets. METOZOLV ODT is indicated for the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis and for the treatment of short–term therapy for adults with symptomatic documented gastroesophageal reflux disease who fail to respond to conventional therapy.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
Genzyme, 11/19/09
Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09
Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09
Genzyme Receives Complete Response Letter on Lumizyme Application
Genzyme, 11/17/09
Article Search
Sponsor